excellent platform to integrate IVL’s existing specialties business with Sinterama’s strong production base. The highly complementary portfolio, customer base and geographical footprint of the two companies
further acquire the remaining 26% equity stake in PT. Indorama Petrochemicals (“PTIP”), a PTA manufacturing plant in Indonesia from PT. Indo-Rama Synthetics Tbk., a connected party. Rationale of the
million, increased 41.4% over the same period last year and increased 21.0% over last quarter due to strong customer demand in cloud storage and data center-related products such as Critical Infrastructure
functional drinks (+26.2 YoY). Domestic beverage continued showing strong growth at 4.6% YoY from both energy drinks and functional drinks. Speed-up health and hygiene innovations made a turnaround of domestic
Reported EPS less Inventory gains/(losses) less one-time extraordinary items Indorama Ventures 3rd Quarter 2018 MD&A 3 Financial Highlights IVL continued its strong performance in 3Q 2018, with growth in
solution and other medical product manufacturing and trading business. Previously the company held 44% of all shares. Later in February 2018, the company acquired additional shares from one of the
population and relatively low consumption level primed for expansion. OSP also leveraged its strong expertise in glass manufacturing in the overseas market, investing in Myanmar’s only glass bottle factory
geographies. This performance reflects strong demand for our products, structurally higher margins and utilization rates, and the results of our long-term investment strategy. The business remains focused to
major customers, new model launch and new product launch led to higher revenues. Thailand operations were very strong; recording 68.3% growth year-on-year. China and Portugal operation were also strong
streamlining the offers of prepaid packages. Broadband and Enterprise business remains a strong growth engine Broadband revenue maintained its growth momentum with an increased subscriber base amid a price